Book contents
- Practical Pathology of Serous Membranes
- Practical Pathology of Serous Membranes
- Copyright page
- Contents
- Contributors
- Preface
- 1 The Mesothelium
- 2 Classification of Neoplastic and Non-neoplastic Lesions of the Serosal Surfaces
- 3 Multi-modality Imaging of Pleural and Peritoneal Disease
- 4 Processing of Pleural and Peritoneal Pathologic Specimens for the Diagnosis of Malignant Mesothelioma
- 5 Cytology of Pleural and Peritoneal Lesions
- 6 Surgical Pathology of Non-neoplastic Conditions of the Pleura, Pericardium, and Peritoneum
- 7 Surgical Pathology of Benign Lesions of Mesothelial Origin
- 8 Epidemiology, Etiology, and Pathogenesis of Malignant Mesothelioma
- 9 Pathologic “Markers” of Above Background Asbestos Exposure
- 10 Molecular Aspects of Malignant Mesothelioma and Other Tumors of the Pleura and Peritoneum
- 11 Pathology of Malignant Mesothelioma
- 12 Surgical Treatment of Pleural and Peritoneal Mesothelioma
- 13 Non-surgical Treatment of Malignant Mesothelioma
- 14 Primary Carcinoma of the Pleura and Peritoneum
- 15 Lymphoid Malignancies of the Pleura and Peritoneum
- 16 Mesenchymal and Other Unusual Tumors of the Pleura and Peritoneum
- Index
- References
12 - Surgical Treatment of Pleural and Peritoneal Mesothelioma
Published online by Cambridge University Press: 16 March 2018
Book contents
- Practical Pathology of Serous Membranes
- Practical Pathology of Serous Membranes
- Copyright page
- Contents
- Contributors
- Preface
- 1 The Mesothelium
- 2 Classification of Neoplastic and Non-neoplastic Lesions of the Serosal Surfaces
- 3 Multi-modality Imaging of Pleural and Peritoneal Disease
- 4 Processing of Pleural and Peritoneal Pathologic Specimens for the Diagnosis of Malignant Mesothelioma
- 5 Cytology of Pleural and Peritoneal Lesions
- 6 Surgical Pathology of Non-neoplastic Conditions of the Pleura, Pericardium, and Peritoneum
- 7 Surgical Pathology of Benign Lesions of Mesothelial Origin
- 8 Epidemiology, Etiology, and Pathogenesis of Malignant Mesothelioma
- 9 Pathologic “Markers” of Above Background Asbestos Exposure
- 10 Molecular Aspects of Malignant Mesothelioma and Other Tumors of the Pleura and Peritoneum
- 11 Pathology of Malignant Mesothelioma
- 12 Surgical Treatment of Pleural and Peritoneal Mesothelioma
- 13 Non-surgical Treatment of Malignant Mesothelioma
- 14 Primary Carcinoma of the Pleura and Peritoneum
- 15 Lymphoid Malignancies of the Pleura and Peritoneum
- 16 Mesenchymal and Other Unusual Tumors of the Pleura and Peritoneum
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Practical Pathology of Serous Membranes , pp. 176 - 182Publisher: Cambridge University PressPrint publication year: 2018
References
Henley, SJ, Larson, TC, Wu, M, Antao, VC, Lewis, M, Pinheiro, GA, et al. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008. Int J Occup Environ Health. 2013;19(1):1–10.CrossRefGoogle ScholarPubMed
Moolgavkar, SH, Meza, R, Turim, J. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005. Cancer Causes Control. 2009;20(6):935–44.Google Scholar
Vigneswaran, WT, Stefanacci, PR. Pericardial mesothelioma. Curr Treat Options Oncol. 2000;1(4):299–302.CrossRefGoogle ScholarPubMed
Miller, A. Mesothelioma in household members of asbestos-exposed workers: 32 United States cases since 1990. Am J Ind Med. 2005;47(5):458–62.Google Scholar
Carbone, M, Rizzo, P, Pass, H. Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res. 2000;20(2A):875–77.Google ScholarPubMed
Rizzo, P, Bocchetta, M, Powers, A, Foddis, R, Stekala, E, Pass, HI, Carbone, M. SV40 and the pathogenesis of mesothelioma. Semin Cancer Biol. 2001;11(1):63–71.CrossRefGoogle ScholarPubMed
Baris, YI, Grandjean, P. Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. J Natl Cancer Inst. 2006;98(6):414–17.Google Scholar
Carbone, M, Emri, S, Dogan, AU, Steele, I, Tuncer, M, Pass, HI, et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer. 2007;7(2):147–54.CrossRefGoogle ScholarPubMed
Zauderer, MG, Bott, M, McMillan, R, Sima, CS, Rusch, V, Krug, LM, et al. Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations. J Thorac Oncol. 2013;8(11):1430–33.CrossRefGoogle ScholarPubMed
Farioli, A, Violante, FS, Mattioli, S, Curti, S, Kriebel, D. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control. 2013;24(8):1535–45.Google Scholar
Gentiloni, N, Febbraro, S, Barone, C, Lemmo, G, Neri, G, Zannoni, G, Capelli, A, Gasbarrini, G. Peritoneal mesothelioma in recurrent familial peritonitis. J Clin Gastroenterol. 1997:24(4):276–79.Google Scholar
Law, MR, Hodson, ME, Heard, BE. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax. 1982;37(11):810–15.Google Scholar
Antman, K, Shemin, R, Ryan, L, Klegar, K, Osteen, R, Herman, T, et al. Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965–1985. J Clin Oncol. 1988;6(1):147–53.CrossRefGoogle Scholar
Camacho, LH, Mora-Bowen, A, Munden, R, Smythe, WR, Ordoñez, NG. Malignant mesothelioma: natural history, pathologic features and future therapies. Am J Med. 2007;120(7):e7–9.CrossRefGoogle ScholarPubMed
Sridhar, KS, Doria, R, Raub, WA, Thurer, RJ, Saldana, M. New strategies are needed in diffuse malignant mesothelioma. Cancer 1992;70(12):2969–79.Google Scholar
Flores, RM, Riedel, E, Donington, JS, Alago, W, Ihekweazu, U, Krug, L, et al. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010;5(10):1649–54.CrossRefGoogle Scholar
Flores, RM, Pass, HI, Seshan, VE, Dycoco, J, Zakowski, M, Carbone, M, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135(3):620–26.CrossRefGoogle ScholarPubMed
Rice, D. Standardizing surgical treatment in malignant pleural mesothelioma. Ann Cardiothorac Surg. 2012;1(4):497–501.Google ScholarPubMed
Butchart, EG, Ashcroft, T, Barnsley, WC, Holden, MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976;31:15–24.Google Scholar
Sugarbaker, DJ, Garcia, JP, Richards, WG, Harpole, DH Jr, , Healy-Baldini, E, DeCamp, MM, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg. 1996;224(3):288–94; discussion 294–96.Google Scholar
Cho, BC, Feld, R, Leighl, N, Opitz, I, Anraku, M, Tsao, MS, et al. A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the “SMART” approach for resectable malignant pleural mesothelioma. J Thorac Oncol. 2014;9(3):397–402.Google Scholar
McCormack, PM, Nagasaki, F, Hilaris, BS, Martini, N. Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg. 1982;84:834–42.CrossRefGoogle ScholarPubMed
Burt, BM, Cameron, RB, Mollberg, NM, Kosinski, AS, Schipper, PH, Shrager, JB, et al. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg. 2014;148(1):30–35.Google Scholar
Lang-Lazdunski, L, Bille, A, Lal, R, Cane, P, McLean, E, Landau, D, et al. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol. 2012;7(4):737–43.CrossRefGoogle ScholarPubMed
Mollberg, NM, Vigneswaran, Y, Kindler, HL, Warnes, C, Salgia, R, Husain, AN, et al. Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma. Ann Thorac Surg. 2012;94(4):1086–92.Google Scholar
Minatel, E, Trovo, M, Polesel, J, Baresic, T, Bearz, A, Franchin, G, et al. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up. Lung Cancer. 2014;83(1):78–82.Google Scholar
Rosenzweig, KE, Zauderer, MG, Laser, B, Krug, LM, Yorke, E, Sima, CS, et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2012;83(4):1278–83.Google Scholar
Bölükbas, S, Eberlein, M, Schirren, J. Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma. J Thorac Oncol. 2012;7(5):900–05.Google Scholar
Burkholder, D, Hadi, D, Kunnavakkam, R, Kindler, H, Todd, K, Celauro, AD, et al. Effects of Extended Pleurectomy and Decortication on Quality of Life and Pulmonary Function in Patients With Malignant Pleural Mesothelioma. Ann Thorac Surg. 2015;99(5):1775–80.Google Scholar
Merritt, N, Blewett, CJ, Miller, JD, Bennett, WF, Young, JE, Urschel, JD. Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol. 2001;78(3):171–74.Google Scholar
Taioli, E, Wolf, AS, Flores, RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015;99(2):472–80.Google Scholar
Jin, S, Cao, S, Cao, J, Shen, J, Hu, J, Che, D, et al. Predictive factors analysis for malignant peritoneal mesothelioma. J Gastrointest Surg. 2015;19(2):319–26.Google Scholar
Lee, M, Alexander, HR, Burke, A. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumors treated with cytoreductive therapy. Pathology. 2013; 45(3):464–73.Google Scholar
Husain, AN, Colby, T, Ordonez, N, Krausz, T, Attanoos, R, Beasley, MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update for the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013;137(5):647–67.Google Scholar
Nakashima, K, Inatsu, H, Kitamura, K, Hikosaka, T, Hoshiko, S, Ashiduka, S. Advanced diffuse malignant peritoneal mesothelioma responding to palliative chemotherapy. Clin J Gastroenterol. 2012;5(6):373–76.CrossRefGoogle ScholarPubMed
Karpathiou, G, Argiana, E, Koutsopoulos, A, Froudarakis, ME. Response of a patient with pleural and peritoneal mesothelioma after second-line chemotherapy with lipoplatin and gemcitabine. Oncology. 2007;73(5–6):426–29.Google Scholar
Alexander, HR, Hanna, N, Pingpank, JF. Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma. Cancer Treat Res. 2007;134:343–55.Google Scholar
Deraco, M, Bartlett, D, Kusamura, S, Baratti, D. Consensus statement on peritoneal mesothelioma. J Surg Oncol. 2008;98(4):268–72.Google Scholar
Turner, KM, Varghese, S, Alexander, HR Jr. Surgery for peritoneal mesothelioma. Curr Treat Options Oncol. 2011;12(2):189–200.CrossRefGoogle ScholarPubMed
Yan, TD, Haveric, N, Carmignani, CP, Chang, D, Sugarbaker, PH. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer. 2005;103(4):839–49.Google Scholar
Low, RN, Barone, RM. Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2012;19(5):1394–1401.Google Scholar
Vilardell, AD, Rasiej, MJ, Taub, RN, Ichise, M. Clinical utility of 18F-Fdg positron emission tomography in malignant peritoneal mesothelioma. Q J Nucl Med Mol Imaging. 2016;60(1):54–61.Google Scholar
Klumpp, BD, Schwenzer, N, Aschoff, P, Miller, S, Kramer, U, Claussen, CD, et al. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. Abdom Imaging. 2013;38(1):64–71.CrossRefGoogle ScholarPubMed
Tabrizian, P, Jayakrishnan, TT, Zacharias, A, Aycart, S, Johnston, FM, Sarpel, U, et al. Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: a multi-institutional analysis. J Surg Oncol. 2015;111(8):1035–40.Google Scholar
Iversen, LH, Rasmussen, PC, Laurberg, S. Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg. 2013;100(2):285–92.Google Scholar
Cotte, E, Passot, G, Gilly, FN, Glehen, O. Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol. 2010;2(1):31–35.CrossRefGoogle ScholarPubMed
Halkia, E, Tsochrinis, A, Vassiliadou, DT, Pavlakou, A, Vaxevanidou, A, Datsis, A, et al. Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. Int J Surg Oncol. 2015;2015:610597.Google Scholar
Qi, D, Hu, Y, Li, J, Peng, T, Su, J, He, Y, et al. Hyperthermia induces apoptosis of 786-O cells through suppressing Ku80 expression. PLoS ONE. 2015;10(4):e0122977.Google Scholar
Hubert, J, Thiboutot, E, Dubé, P, Cloutier, AS, Drolet, P, Sideris, L. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: preliminary results and survival analysis. Surg Oncol. 2015;24(1):41–46.CrossRefGoogle ScholarPubMed
Helm, JH, Miura, JT, Glenn, JA, Marcus, RK, Larrieux, G, Jayakrishnan, TT, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22(5):1686–93.Google Scholar
Yan, TD, Deraco, M, Baratti, D, Kusamura, S, Elias, D, Glehen, O, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27(36):6237–42.Google Scholar
Baratti, D, Kusamura, S, Cabras, AD, Dileo, P, Laterza, B, Deraco, M. Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2009;16(2):463–72.CrossRefGoogle ScholarPubMed